Invention Application
- Patent Title: PYRROLO[1,2-f][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS
-
Application No.: US15610104Application Date: 2017-05-31
-
Publication No.: US20180016280A1Publication Date: 2018-01-18
- Inventor: Michael O' Neil Hanrahan Clarke , Edward Doerffler , Richard L. Mackman , Dustin Siegel
- Applicant: Gilead Sciences, Inc.
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07F9/6561 ; C07D405/14 ; C07H7/06 ; C07D405/04
![PYRROLO[1,2-f][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS](/abs-image/US/2018/01/18/US20180016280A1/abs.jpg.150x150.jpg)
Abstract:
Provided herein are formulations, methods and substituted tetrahydrofuranyl-pyrrolo[1,2-f][1,2,4]triazine-4-amine compounds of Formula (I) for treating Pneumovirinae virus infections, including respiratory syncytial virus infections, as well as methods and intermediates for synthesis of tetrahydrofuranyl-pyrrolo[1,2-f][1,2,4]triazine-4-amine compounds.
Public/Granted literature
- US10059716B2 Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections Public/Granted day:2018-08-28
Information query